We are monitoring the impact of COVID-19 on Preclinical CRO Agents Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 6459
Share on
Share on

Global Preclinical CRO Agents Market Analysis - By Service type (Bioanalysis and DMPK studies, Toxicology testing, Other preclinical services), By End user (Biopharmaceutical companies, Government and academic institutes, Medical device companies), By Region - Industry Size, Share, Trends, Forecast and Growth | 2019 - 2024

Pulished: February, 2020
ID: 6459
Pages: 175

Preclinical CRO Agents Market Size & Growth (2019 - 2024)

Global Preclinical CRO Agents Market was worth USD 3.52 billion in 2019 and estimated to be growing at a CAGR of 8.3%, to reach USD 5.24 billion by 2024. 

A preclinical contract research organization is the guiding force for pharmaceutical companies advising how to take a drug from the research laboratories to the market. It requires various professionals including medical personnel, administrators and marketing experts. Preclinical research is of prime importance and has various risks associated with it. This is the phase where there is a high chance that a product might fail and hence choosing a CRO becomes of prime importance.

The increasing number of life science of companies and outsourcing of various functions is driving the market growth. The rising number of R&D projects in the clinical phase segment is further propelling market growth. Due to the failure of toxicology tests, the market is growing significantly. Supportive government policies regarding drug approval are expected to fuel the market growth during the forecast period.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 – 2024

Segments Analysed

By Service Type, By End User

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Analysed

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Companies Analysed

Charles River Laboratories International, Inc.; Laboratory Corporation of America; Envigo, Eurofins Scientific; PRA Health Science, Inc.; Wuxi AppTec; Medpace, Inc.; Pharmaceutical Product Development, LLC.; and Paraxel International Corporation.

 

This research report on the Global Preclinical CRO Agents Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2024.

Preclinical CRO Agents Market - By Service type                               

  • Bioanalysis and DMPK studies        
  • Toxicology testing
  • Other preclinical services  

On the basis of service type, the Toxicology testing holds the largest market share in the preclinical CRO market.

Preclinical CRO Agents Market - By End-user                      

  • Biopharmaceutical companies        
  • Government and academic institutes         
  • Medical device companies               

On the basis of end-user, the Biopharmaceutical companies are the biggest end-user segment for preclinical CRO.

Regional Analysis

The market is analyzed under various regions namely North America, Europe, Asia-Pacific and Rest of the World. The Preclinical CRO agent market was dominated by North America closely followed Europe. Asia Pacific is expected to grow at a high CAGR.

Some of the major companies dominating the Global Preclinical CRO Agents Market profiled in the report are:

  1. Charles River Laboratories International, Inc.
  2. Laboratory Corporation of America
  3. Envigo
  4. Eurofins Scientific
  5. PRA Health Science, Inc.
  6. Wuxi AppTec
  7. Medpace, Inc.
  8. Pharmaceutical Product Development, LLC.
  9. Paraxel International Corporation

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Service type                               

                                5.1.1 Introduction           

                                5.1.2 Bioanalysis and DMPK studies        

                                5.1.3 Toxicology testing

                                5.1.4 Other preclinical services  

                                5.1.5  Y-o-Y Growth Analysis, By service type      

                                5.1.6  Market Attractiveness Analysis, By service type    

                                5.1.7  Market Share Analysis, By service type     

                5.2 End user                      

                                5.2.1 Introduction           

                                5.2.2 Biopharmaceutical companies        

                                5.2.3 Government and academic institutes         

                                5.2.4 Medical device companies               

                                5.2.5 Y-o-Y Growth Analysis, By end user             

                                5.2.6 Market Attractiveness Analysis, By end user           

                                5.2.7 Market Share Analysis, By end user             

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By service type

                                                6.1.3.3 By end user

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By service type

                                                6.1.4.3 By end user

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By service type

                                                6.1.5.3 By end user

                6.2 North America                          

                                6.2.1 Introduction           

                                6.2.2 United States         

                                6.2.3 Canada     

                6.3 Europe                         

                                6.3.1 Introduction           

                                6.3.2 U.K             

                                6.3.3 Spain         

                                6.3.4 Germany 

                                6.3.5 Italy            

                                6.3.6 France       

                6.4 Asia-Pacific                 

                                6.4.1 Introduction           

                                6.4.2 China         

                                6.4.3 India          

                                6.4.4 Japan         

                                6.4.5 Australia   

                                6.4.6 South Korea           

                6.5 Latin America                             

                                6.5.1 Introduction           

                                6.5.2 Brazil          

                                6.5.3 Argentina

                                6.5.4 Mexico     

                                6.5.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.6.1 Introduction           

                                6.6.2 Middle-East            

                                6.6.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Charles River Laboratories International, Inc                

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Laboratory Corporation of America                  

                8.3 Envigo                           

                8.4 Eurofins Scientific                    

                8.5 PRA Health Science, Inc                         

                8.6 Wuxi AppTec                             

                8.7 Medpace, Inc                            

                8.8 Pharmaceutical Product Development, LLC                  

                8.9 Paraxel International Corporation                    

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms by end user along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Preclinical CRO Market By Region, From 2019-2024 ( USD Billion )
  2. Global Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  3. Global Bioanalysis and DMPK studies Market By Region, From 2019-2024 ( USD Billion )
  4. Global Toxicology testing Market By Region, From 2019-2024 ( USD Billion )
  5. Global Other preclinical services Market By Region, From 2019-2024 ( USD Billion )
  6. Global Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  7. Global Biopharmaceutical companies Market By Region, From 2019-2024 ( USD Billion )
  8. Global Govermenta and academic institutes Market By Region, From 2019-2024 ( USD Billion )
  9. Global Medical device companies Market By Region, From 2019-2024 ( USD Billion )
  10. North America Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  11. North America Bioanalysis and DMPK studies Market By Region, From 2019-2024 ( USD Billion )
  12. North America Toxicology testing Market By Region, From 2019-2024 ( USD Billion )
  13. North America Other preclinical services Market By Region, From 2019-2024 ( USD Billion )
  14. North America Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  15. North America Biopharmaceutical companies Market By Region, From 2019-2024 ( USD Billion )
  16. North America Govermenta and academic institutes Market By Region, From 2019-2024 ( USD Billion )
  17. North America Medical device companies Market By Region, From 2019-2024 ( USD Billion )
  18. United States Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  19. United States Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  20. Canada Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  21. Canada Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  22. Europe Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  23. Europe Bioanalysis and DMPK studies Market By Region, From 2019-2024 ( USD Billion )
  24. Europe Toxicology testing Market By Region, From 2019-2024 ( USD Billion )
  25. Europe Other preclinical services Market By Region, From 2019-2024 ( USD Billion )
  26. Europe Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  27. Europe Biopharmaceutical companies Market By Region, From 2019-2024 ( USD Billion )
  28. Europe Govermenta and academic institutes Market By Region, From 2019-2024 ( USD Billion )
  29. Europe Medical device companies Market By Region, From 2019-2024 ( USD Billion )
  30. U.K. Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  31. U.K. Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  32. Germany Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  33. Germany Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  34. France Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  35. France Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  36. Italy Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  37. Italy Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  38. Spain Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  39. Spain Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  40. Asia Pacific Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  41. Asia Pacific Bioanalysis and DMPK studies Market By Region, From 2019-2024 ( USD Billion )
  42. Asia Pacific Toxicology testing Market By Region, From 2019-2024 ( USD Billion )
  43. Asia Pacific Other preclinical services Market By Region, From 2019-2024 ( USD Billion )
  44. Asia Pacific Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  45. Asia Pacific Biopharmaceutical companies Market By Region, From 2019-2024 ( USD Billion )
  46. Asia Pacific Govermenta and academic institutes Market By Region, From 2019-2024 ( USD Billion )
  47. Asia Pacific Medical device companies Market By Region, From 2019-2024 ( USD Billion )
  48. Japan Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  49. Japan Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  50. China Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  51. China Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  52. India Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  53. India Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  54. Australia Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  55. Australia Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  56. South Korea Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  57. South Korea Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  58. Latin America Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  59. Latin America Bioanalysis and DMPK studies Market By Region, From 2019-2024 ( USD Billion )
  60. Latin America Toxicology testing Market By Region, From 2019-2024 ( USD Billion )
  61. Latin America Other preclinical services Market By Region, From 2019-2024 ( USD Billion )
  62. Latin America Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  63. Latin America Biopharmaceutical companies Market By Region, From 2019-2024 ( USD Billion )
  64. Latin America Govermenta and academic institutes Market By Region, From 2019-2024 ( USD Billion )
  65. Latin America Medical device companies Market By Region, From 2019-2024 ( USD Billion )
  66. Brazil Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  67. Brazil Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  68. Argentina Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  69. Argentina Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  70. Mexico Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  71. Mexico Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  72. Rest of Latin America Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  73. Rest of Latin America Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  74. Middle East and Africa Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  75. Middle East and Africa Bioanalysis and DMPK studies Market By Region, From 2019-2024 ( USD Billion )
  76. Middle East and Africa Toxicology testing Market By Region, From 2019-2024 ( USD Billion )
  77. Middle East and Africa Other preclinical services Market By Region, From 2019-2024 ( USD Billion )
  78. Middle East and Africa Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  79. Middle East and Africa Biopharmaceutical companies Market By Region, From 2019-2024 ( USD Billion )
  80. Middle East and Africa Govermenta and academic institutes Market By Region, From 2019-2024 ( USD Billion )
  81. Middle East and Africa Medical device companies Market By Region, From 2019-2024 ( USD Billion )
  82. Middle East Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  83. Middle East Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  84. Africa Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  85. Africa Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample